» Articles » PMID: 10657646

Murine Pro-B Cells Require IL-7 and Its Receptor Complex to Up-regulate IL-7R Alpha, Terminal Deoxynucleotidyltransferase, and C Mu Expression

Overview
Journal J Immunol
Date 2000 Feb 5
PMID 10657646
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Phenotypic analysis of bone marrow cells from IL-7 knockout (KO) mice revealed that B cell development is blocked precisely at the transition between pro-B cells and pre-B cells. In contrast, the generation of pre-pro-B cells and pro-B cells appeared to be normal, as judged by total cell numbers, proliferative indexes, D-JH and V-DJH gene rearrangements, and mRNA for recombinase-activating gene-1 (RAG-1), RAG-2, TdT, Ig mu, lambda 5, and VpreB. However, upon closer inspection, several abnormalities in pro-B cell development were identified that could be corrected by injection of rIL-7 in vivo. These included the absence of the subset of late pro-B cells that initiates cmu expression for pre-B cell Ag receptor (BCR) formation, and the failure of pro-B cells to up-regulate TdT and the IL-7R alpha (but not the common gamma-chain) chain. Similar defects were present in common gamma-chain and Jak3 KO mice, but not in lambda 5 or (excluding cytoplasmic Ig mu heavy chain (c mu)) RAG-1 KO mice, all of which also arrest at the late pro-B cell stage. Consequently, up-regulation of TdT and IL-7R alpha expression requires signaling through the high affinity IL-7R, but does not require cmu expression or a functional pre-BCR. Taken together, these results suggest that IL-7 and its receptor complex are essential for 1) up-regulating the expression of TdT and IL-7R alpha, 2) initiating the production of cmu and 3) promoting the formation of a functional pre-BCR in/on pro-B cells. These key events, in turn, appear to be prerequisite both for differentiation of pro-B cells to pre-B cells and for proliferation of these cell subsets upon continued stimulation with IL-7.

Citing Articles

Low IL7R Expression at Diagnosis Predicted Relapse in Adult Acute Myeloid Leukemia Patients With t(8;21).

Xu N, Sun K, Wang Y, Chen W, Wang J, Li L Front Immunol. 2022; 13:909104.

PMID: 35874754 PMC: 9302488. DOI: 10.3389/fimmu.2022.909104.


The Broad Immunomodulatory Effects of IL-7 and Its Application In Vaccines.

Huang J, Long Z, Jia R, Wang M, Zhu D, Liu M Front Immunol. 2021; 12:680442.

PMID: 34956167 PMC: 8702497. DOI: 10.3389/fimmu.2021.680442.


The lymphoid-associated interleukin 7 receptor (IL7R) regulates tissue-resident macrophage development.

Leung G, Cool T, Valencia C, Worthington A, Beaudin A, Forsberg E Development. 2019; 146(14).

PMID: 31332039 PMC: 6679362. DOI: 10.1242/dev.176180.


Cell circuits and niches controlling B cell development.

Zehentmeier S, Pereira J Immunol Rev. 2019; 289(1):142-157.

PMID: 30977190 PMC: 6464388. DOI: 10.1111/imr.12749.


The E3 ubiquitin ligase Itch is required for B-cell development.

Liu X, Zhang Y, Wei Y, Wang Z, Zhu G, Fang Y Sci Rep. 2019; 9(1):421.

PMID: 30674954 PMC: 6344599. DOI: 10.1038/s41598-018-36844-9.